- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
How Much Do You Really Know About Pharma: Quiz Answers
Find out how you did on our December 2005 quiz.
ANSWERS:
1. The African clawed frog (Xenopus laevis)
2. The researchers rubbed spores of the Penicillium mold into the fabric of their lab coats.
3. Asprin (acetylsalicylic acid)
4. Travelers were to bring back soil samples from the locations they visited. The soil fungus from which Cyclosporine was derived was collected in Norway.
5. Hoffman acetylated morphine, creating heroin.
6. Actually, there were two, Robert Wood Johnson’s brothers James and Edward Mead.
7. Tetracycline
8. Vitamin C (ascorbic acid)
9. “It has not escaped our notice . . .” comes from Watson and Crick’s 1953 Nature article on the structure of DNA. What hadn’t escaped their notice was the fact that the double helix structure they proposed suggested possible copying mechanism for genetic material.
10. Perkins, then 18, was trying to create a synthetic form of quinine.
11. Microbiologist and Nobel Prize winner Selman Waksman discovered streptomycin.
12. Photographer Janet Parker, the world’s last victim of smallpox, died. She apparently was infected by virus that escaped from a laboratory containment.
13. The odd company out is Neutrogena, which is owned by Johnson & Johnson. The rest are part of Pfizer.
14. Sudafed (pseudoephedrine)
15. The Wisconsin Alumni Research Foundation
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
